In Re: Nps Pharmaceuticals, Inc.
This text of In Re: Nps Pharmaceuticals, Inc. (In Re: Nps Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
IN RE: NPS PHARMACEUTICALS, INC., Appellant ______________________
2017-1392, 2017-1393 ______________________
Appeals from the United States Patent and Trade- mark Office, Patent Trial and Appeal Board in Nos. IPR2015-00990, IPR2015-01093. ______________________
JUDGMENT ______________________
JOSEPH R. ROBINSON, Troutman Sanders LLP, New York, NY, argued for appellant. Also represented by ROBERT SCHAFFER; DUSTIN B. WEEKS, Atlanta, GA. ______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (PROST, Chief Judge, DYK and CHEN, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT
November 15, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
In Re: Nps Pharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-nps-pharmaceuticals-inc-cafc-2017.